businesspress24.com - Equity Research on The Dow Chemical Company and EI DuPont de Nemours & Co. - New Products and Ap
 

Equity Research on The Dow Chemical Company and EI DuPont de Nemours & Co. - New Products and Approaches for Chemical Companies

ID: 1113860

(firmenpresse) - JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 05/14/12 -- offers investors comprehensive research on the Chemicals industry and has completed analytical research on (NYSE: DOW) and (NYSE: DD). Register with us today at to have free access to these researches.

The problems stemming from the sputtering U.S. economy and the Eurozone crisis have continued to pose challenges for companies such as The Dow Chemical Company and EI DuPont de Nemours & Co. In an attempt to address these issues and grow sales and earnings, companies have been taking a number of steps. Register now at to have free access to our reports on the Chemicals industry.

is an online platform where investors doing their due-diligence on the Chemicals industry can have easy and free access to our analyst research and opinions on The Dow Chemical Company and EI DuPont de Nemours & Co.; investors and shareholders of these companies can simply register for a complimentary membership at .

Some companies, such as DuPont, have been releasing new products and making acquisitions. DuPont recently stated that it now has full ownership of Solae, after it bought out its joint venture partner Bunge. Before the deal DuPont owned a 72% stake in the soy-based ingredients company. research report is available for free by signing up now at .

Others have been focusing on restructuring their operations to best compete in today's competitive marketplace. While restructuring can prove to be a positive in the long-term, the expense can negatively affect short-term quarterly results. Dow chemical saw its 1st quarter profits decline significantly, in part due to high restructuring costs. Divesting underperforming assets has also been a theme for companies looking to streamline their operations, while others have been looking to expand abroad. research report is accessible for free by registering today at .

Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future.





StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Arena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years
Anti-Obesity Drugs a Hot Topic in the Biotech Industry
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 14.05.2012 - 06:20 Uhr
Sprache: Deutsch
News-ID 1113860
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

JOHANNESBURG, SOUTH AFRICA


Phone:

Kategorie:

Investment Services & Trading


Anmerkungen:


Diese Pressemitteilung wurde bisher 164 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Equity Research on The Dow Chemical Company and EI DuPont de Nemours & Co. - New Products and Approaches for Chemical Companies
"
steht unter der journalistisch-redaktionellen Verantwortung von

StockCall (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von StockCall



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 241


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.